Education
About Us
Working with TipRanks
Follow Us
Bruker Corp (BRKR)
NASDAQ:BRKR
BRKR Analyst Ratings
Moderate Buy
8 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BRKR Stock 12 Month Forecast
Average Price Target
$56.50
▲(39.47% Upside)
| Highest Price Target$80.00 | Average Price Target$56.50 | Lowest Price Target$45.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Stifel Nicolaus
Reiterated
05/08/25
Bank of America Securities
Reiterated
05/07/25
Cleveland Research
Downgraded
04/24/25
Leerink Partners
Reiterated
04/17/25
Jefferies
$80
Buy
97.48%
Upside
Reiterated
02/28/25
Bruker's Promising Market Position and Growth Prospects Justify Buy RatingWe highlight the the UK recently took delivery and began installation of an ultra-high field 1.2 GHz NMR system, representing the 10th EU placement. This marks the 1st GHz NMR delivery in '25 (guide assumes three). Stepping back, all focus has been on NIH noise, but we see plenty of positives (semi, microbiology, Elitech, Chemspeed), an attractive margin runway, and valuation (14x EBITDA/18x PE on '25E) that is not demanding. Reit. Buy.
Goldman Sachs
―
Hold
―
Upgraded
12/05/24
Goldman Sachs upgrades Bruker (BRKR) to NeutralGoldman Sachs analyst Matthew Sykes upgraded Bruker (NASDAQ: BRKR) from Sell to Neutral with a price target of $60.00.
Wolfe Research
―
Hold
―
Downgraded
09/30/24
Bruker (BRKR) was downgraded to a Hold Rating at Wolfe Research
Nephron
$65
Sell
60.45%
Upside
Downgraded
05/29/24
Nephron downgrades Bruker (BRKR) to SellNephron analyst Jack Meehan downgraded Bruker (NASDAQ: BRKR) from Hold to Sell with a price target of $65.00.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stifel Nicolaus
Reiterated
05/08/25
Bank of America Securities
Reiterated
05/07/25
Cleveland Research
Downgraded
04/24/25
Leerink Partners
Reiterated
04/17/25
Jefferies
$80
Buy
97.48%
Upside
Reiterated
02/28/25
Bruker's Promising Market Position and Growth Prospects Justify Buy RatingWe highlight the the UK recently took delivery and began installation of an ultra-high field 1.2 GHz NMR system, representing the 10th EU placement. This marks the 1st GHz NMR delivery in '25 (guide assumes three). Stepping back, all focus has been on NIH noise, but we see plenty of positives (semi, microbiology, Elitech, Chemspeed), an attractive margin runway, and valuation (14x EBITDA/18x PE on '25E) that is not demanding. Reit. Buy.
Goldman Sachs
―
Hold
―
Upgraded
12/05/24
Goldman Sachs upgrades Bruker (BRKR) to NeutralGoldman Sachs analyst Matthew Sykes upgraded Bruker (NASDAQ: BRKR) from Sell to Neutral with a price target of $60.00.
Wolfe Research
―
Hold
―
Downgraded
09/30/24
Bruker (BRKR) was downgraded to a Hold Rating at Wolfe Research
Nephron
$65
Sell
60.45%
Upside
Downgraded
05/29/24
Nephron downgrades Bruker (BRKR) to SellNephron analyst Jack Meehan downgraded Bruker (NASDAQ: BRKR) from Hold to Sell with a price target of $65.00.
Best Analysts Covering Bruker
Which Analyst Should I Follow If I Want to Buy BRKR and Sell After:
1 Month
xxx
Success Rate
14/30 ratings generated profit
Average Return
+0.49%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 46.67% of your transactions generating a profit, with an average return of +0.49% per trade.
3 Months
xxx
Success Rate
6/14 ratings generated profit
Average Return
-2.93%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -2.93% per trade.
1 Year
Success Rate
16/30 ratings generated profit
Average Return
+3.65%
reiterated a buy rating 3 days ago
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 53.33% of your transactions generating a profit, with an average return of +3.65% per trade.
2 Years
xxx
Success Rate
20/30 ratings generated profit
Average Return
+11.14%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +11.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BRKR Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
2
5
6
9
5
Buy
15
14
12
10
8
Hold
5
5
3
4
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
24
21
23
18
Each month's total comprises the sum of three months' worth of ratings.
BRKR Financial Forecast
BRKR Stock Forecast FAQ
What is BRKR’s average 12-month price target, according to analysts?
Based on analyst ratings, Bruker Corp’s 12-month average price target is 56.50.
What is BRKR’s upside potential, based on the analysts’ average price target?
Bruker Corp has 39.47% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BRKR a Buy, Sell or Hold?
Bruker Corp has a consensus rating of Moderate Buy which is based on 8 buy ratings, 4 hold ratings and 0 sell ratings.
What is Bruker Corp’s price target?
The average price target for Bruker Corp is 56.50. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $80.00 ,the lowest forecast is $45.00. The average price target represents 39.47% Increase from the current price of $40.51.
The highest analyst price target is $80.00 ,the lowest forecast is $45.00. The average price target represents 39.47% Increase from the current price of $40.51.
What do analysts say about Bruker Corp?
Bruker Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of BRKR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.